Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000908733-08-000227
Filing Date
2008-01-24
Accepted
2008-01-24 16:03:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 COLLAGENEX PHARMACEUTICALS INC 13GA1 collagenexpharmaceuticals.htm SC 13G/A 11420
  Complete submission text file 0000908733-08-000227.txt   13639
Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 3126349231
COLUMBIA WANGER ASSET MANAGEMENT LP (Filed by) CIK: 0000908733 (see all company filings)

EIN.: 363820584 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Subject) CIK: 0001012270 (see all company filings)

EIN.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47825 | Film No.: 08547668
SIC: 2834 Pharmaceutical Preparations